The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*

Aim of the study was to analyze the outcome of treatment and factors predicting results of sorafenib therapy in inoperable/metastatic CD117-positive GIST patients after failure on imatinib and sunitinib. Material and methods : We identified 60 consecutive patients (40 men, 20 women) with advanced...

Full description

Bibliographic Details
Main Authors: Piotr Rutkowski, Beata Jagielska, Jolanta Andrzejuk, Elzbieta Bylina, Iwona Lugowska, Tomasz Switaj, Hanna Kosela-Paterczyk, Katarzyna Kozak, Slawomir Falkowski, Anna Klimczak
Format: Article
Language:English
Published: Termedia Publishing House 2017-12-01
Series:Contemporary Oncology
Subjects:
gastrointestinal stromal tumor
sorafenib
metastases
therapy
Online Access:https://www.termedia.pl/The-analysis-of-the-long-term-outcomes-of-sorafenib-therapy-in-routine-practice-in-imatinib-and-sunitinib-resistant-gastrointestinal-stromal-tumors-GIST-,3,31353,1,1.html

Internet

https://www.termedia.pl/The-analysis-of-the-long-term-outcomes-of-sorafenib-therapy-in-routine-practice-in-imatinib-and-sunitinib-resistant-gastrointestinal-stromal-tumors-GIST-,3,31353,1,1.html

Similar Items